Skip to content

the Association Between Blood's and Urinary Heavy Metal Level in Pregnant Women and the Spontaneous Abortion

Department of Gynecology and Obstetrics From Peking Union Medical College Hospital

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03332706
Acronym
HMLandSA
Enrollment
200
Registered
2017-11-06
Start date
2017-10-10
Completion date
2018-11-30
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heavy Metal Toxicity, Spontaneous Abortion

Brief summary

The aim of the study was to define the possible association between heavy iron level and the consequence of pregnancy especially spontaneous abortion and missed abortion. The study population will comprised the first-trimester pregnant women in the PUMCH (Peking Union Medicine College Hospital) during 2017 October to 2018 November. We categorised the patients into two groups, the study group where the patients suffered from spontaneous abortion or missed abortion, and the control group where the patients carry the normal live fetal for at least 8 weeks and ask for artificial abortion. All the cases included in the study were examined with respect to 6 kinds of heavy iron level in venous blood and urine, then correlation analysis was applied to define heavy iron level between two groups.

Interventions

OTHERobservation

after the subjects are included into the groups,they are asked to do a questionaire.Then,we just observe the outcomes of pregnancy

Sponsors

Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

\- early trimester pregnant women

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
blood's and urinary heavy metal level12months6 kinds of heavy metal:Pb,As,Hg,Gd,Cr,Se

Countries

China

Contacts

Primary ContactLiu xinyan
liuxymeng@163.com18600008013

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026